Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells

Icahn School of Medicine at Mount Sinai Secures $5 Million NIH Grant for Cutting-Edge Cancer Target Discovery and Development Center

Study Reveals a Trio of Immune Cells Vital in Response to Liver Cancer Immunotherapy

Cancer vaccines being developed at the Tisch Cancer Institute at Mount Sinai

She Thought Cancer Had Won — Until This Experimental Therapy

Targeting One Type of Immune Cell With Another Slows Cancer Growth in Preclinical Studies

Novel CRISPR Imaging Technology Reveals Genes Controlling Tumor Immunity

Immunotherapy before surgery killed off liver tumors in one-third of patients, study finds

Libtayo effective in killing HCC tumors prior to resection

Immunotherapy Before Liver Cancer Surgery Can Kill Tumor, and Likely Residual Cancer Cells

Potentially Serious Side Effect Seen in Patient after Immunotherapy